Table 3. Common regulators and targets of differentially expressed genes (from Table 1) identified by Pathway Studio 5 analysis.
| Regulators | Targets |
| Small molecule | Small molecule |
| androgen | androgen |
| Ca2+ | androstenedione |
| cAMP | Ca2+ |
| cholesterol | cAMP |
| dexamethasone | ceramide |
| estradiol | cholesterol |
| estrogen | cortisol |
| fatty acids | estradiol |
| glucocorticoid | estrogen |
| glucose | fatty acids |
| norepinephrine | glutamate |
| phospholipids | lipid |
| progesterone | melanin |
| RA | NO |
| siRNA | progesterone |
| steroids | testosterone |
| testosterone | tyrosine |
| Disorders | Disorders |
| diabetes mellitus | Crohn disease |
| fetal development | dementia |
| inflammation | diabetes mellitus |
| neural tube malformation | digestion |
| neuroblastoma | embryonic cell viability |
| endocrine abnormality | |
| endocrine function | |
| epilepsy | |
| fetal development | |
| hyperandrogenemia | |
| hyperinsulinemia | |
| inflammation | |
| long-term potentiation | |
| muscular dystrophy | |
| neural tube malformation | |
| neuron dysfunction | |
| neuron toxicity | |
| peripheral nerve function |